이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
비즈니스 · 2015. 10. 30.1 분 읽기
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Impact of Ad Exposure Frequency on Perception and Mental Processing of Risks and Benefit Information in Direct-to-Consumer Prescription Drug Ads
로컬 자동 번역 · 원본 출처 언어
요약
The Food and Drug Administration (FDA) is announcing that a collection of information entitled "Impact of Ad Exposure Frequency on Perception and Mental Processing of Risks and Benefit Information in Direct-to-Consumer Prescription Drug Ads" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
원본 출처 언어: Federal Register — Food and Drug Administration원문 발표 열기 →